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Repair? Not so Sure!Vascular clinical practice has changed dramatically during the
last two decades and endovascular techniques prevail for the
majority of arterial pathologies, including occlusive and aneu-
rysmal disease. At present, not a single vascular surgeon considers
that endovascular aneurysm repair (EVR) is a failed experiment. On
the contrary as proven by national registries in Europe and USA,
EVR is by and large the prevailing option for the treatment of aortic
aneurysms (AAA). However, many surgeons will still choose open
repair (OR) for young patients ﬁt for surgery and also for those
with unfavourable EVR anatomy. Are they right?
Ten year outcome data from EVAR-11 showed the questionable
durability of EVR with late endograft related complications
including rupture, some being preventable by timely treatment
of endoleak, but others not foreseen despite thorough follow-up.
Endovascular enthusiasts like Loftus et al, contest the relevance
of EVAR-1 to guide modern vascular practice, arguing that designs
of the latest endografts have markedly improved and that close
surveillance of patients will lower the late AAA mortality of
EVR. Are their arguments good enough to nail the lid on the cofﬁn
of OR, especially for patients deemed ﬁt for surgery? We think
that endovascular enthusiasts are pushing the envelope a little
too far.
Wewould like to agreewith Loftus et al. that endograft improve-
ments and a better understanding and prevention of potential cause
of failure would decrease long term device-related complications.
Unfortunately, the results of recent EVAR series do not foster this
optimism. The ACE trial,2 unsurprisingly not quoted by the authors,
challenges the short term beneﬁts of EVR in low- to moderate-risk
patients with favourable anatomy for EVR. In this randomised trial,
the 30-day mortality was similar between EVR and OR (1.3% vs.
0.6%; p ¼ 1.0). In addition, the ACE trial showed at 3-years, a higher
percentage of reintervention in EVR vs. OR (16% vs. 2.4%, p < 0.001)
and also a trend toward a higher aneurysm-relatedmortality in EVR
vs. OR (4% vs. 0.7%, p¼ 0.12). In another study, Gupta et al.3 analyzed
the data from the US National Surgical Quality Improvement
Program (NSQIP) to compare the 30-day outcomes after OR and
EVR inpatients younger than 60 years. They demonstrated a compa-
rable 30-daymortality between EVR andOR (1.1% vs. 0.4%; p¼ 0.22).
These recent studies using third generation endografts show the
absence of the initial beneﬁt of EVR in term of mortality in patients
ﬁt for OR. In the ACE trial, despite favourable initial anatomy and
close follow-up, rupture occurred after EVR in more than 2% of
cases. The burden of follow-up is well known including the cost of
surveillance and reintervention, together with the radiation1078-5884/$ – see front matter  2012 Published by Elsevier Ltd on behalf of European
doi:10.1016/j.ejvs.2012.03.015exposure associated with a signiﬁcant increase in the risk of solid
cancer, a real threat for young patients.4 We agree with Loftus
et al. that improvements have been made to reduce radiation expo-
surewith the latest generation CT-scanners and the shift toward the
use of Duplex ultrasound for surveillance.5 However a CT-scan
remains mandatory in patients whose aneurysm does not shrink
or in those patients with unclassiﬁed endoleak.
If we go further and exclude patients deemed ﬁt for OR, will all
the remaining patients beneﬁt from a shift towards an EVR exclu-
sive practice as recommended by Loftus et al? We cannot be so
sure Some patient’s characteristics do not meet the criteria for
EVR success and there are gender differences. Women are under-
represented in EVR trials. The reasons are that they generally
present with anatomically unfavourable infrarenal aortic necks
and smaller iliac arteries which may preclude the use of endog-
rafts.6 Age is also a major issue. The advantage of EVR in octogenar-
ians seems intuitively obvious. Not so, if you believe Ballota et al.7
who have shown that OR in octogenarians is associated with
acceptable rates of perioperative mortality and morbidity despite
the fact that the complexity of OR has increased signiﬁcantly in
the era of EVR. What about ﬁtness? Unﬁt or marginally ﬁt patients
may at ﬁrst sight seem to beneﬁt from EVR. But consider the not so
small subgroup of patients 10 years later with a growing aneurysm
despite EVR, failed embolisation, failed stent graft extension and
no longer any chance of surviving an open operation! Some of
these patients may have beneﬁted from an early OR. What about
size? Large aneurysm size has been correlated with a poor
outcome after EVR. Brewster et al.8 demonstrated that large AAA
(diameter  55 mm) was a predictor of perioperative death,
rupture, aneurysm-related mortality and all-cause mortality with
less than 20% of ﬁrst generation devices. Eurostar data base has
shown the same trend toward higher failure rate with large aneu-
rysms.9 The reasons for these failures are unclear. Sweet et al.6
have shown that surgeons often treat patients with large aneu-
rysms that fall outside the recommended instructions for use
(IFU) set by industry. In large aneurysms, endografts being rela-
tively unsupported within the aneurysm cavity, are exposed to
greater haemodynamic stress. Finally large aneurysms are more
prone to persistent Type II endoleak, another factor that may
lead to late failure.
Furthermore, a worrying recent report from Schanzer et al.10
showed that in a large population of patients who underwent EVR
in the United States over a 10-year period, the incidence of AAA
sac enlargement was 41% at 5-years, a rate that increased over theSociety for Vascular Surgery.
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entrycriteria, themain reason for this adverse outcomewas thought
to be related to more liberal indications for EVR and “endo-enthou-
siasts” overlooking the IFU for appropriate patient selection.
It is clear that physicians, patients, industry and institutions
would agree with Loftus’s plea for an “all endo approach” for AAA,
the main reasons being the shorter hospitalisation time, lower
hospital resource consumption and rapid recovery. However, as
with the stock market, a parallel lesson must be drawn by those
caring for patients with aortic aneurysms that an immediate wind-
fall proﬁt does not avoid a risk of late ruin. Moreover what is at stake
with AAA is notmoney but life. So bet on success and choose the best
operation for the individual patient, opting for EVR when the
anatomy is favourable. The choice for the rest is speculative. The
time to nail the lid on the cofﬁn of open surgery has not come yet.References
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